[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@BiotechCH Avatar @BiotechCH Biotech Hangout

Biotech Hangout posts on X about ndaa, $alks, $avdl, $jnj the most. They currently have XXXXXX followers and XX posts still getting attention that total XXXXX engagements in the last XX hours.

Engagements: XXXXX #

Engagements Line Chart

Mentions: X #

Mentions Line Chart

Followers: XXXXXX #

Followers Line Chart

CreatorRank: XXXXXXX #

CreatorRank Line Chart

Social Influence

Social category influence stocks XXXXX% finance XXXX% countries XXXX% cryptocurrencies XXXX%

Social topic influence ndaa #22, $alks 11.76%, $avdl 11.76%, $jnj 11.76%, $llys #1, $3b 5.88%, $mrks 5.88%, $cdtx 5.88%, $arwr 5.88%, rfk XXXX%

Top accounts mentioned or mentioned by @yaronwerber @brianskorney @samfazeli8 @johnbstanford @mbrushstocks @biotech1 @matteispaul @cngarabedian @ericschmidt151 @artsstocks @yaireinhorn @soowannaway @daphnezohar @lifescivc @lifescivcs @tlorriman @adamfeuerstein @msollender @sportsbios @colongracee

Top assets mentioned Alkermes Inc. plc (ALKS) Johnson & Johnson (JNJ) Cidara Therapeutics, Inc. (CDTX) Arrowhead Research Corporation (ARWR) One Cash (ONC) Eli Lilly and Company (LLY) Arcellx, Inc. Common Stock (ACLX) Gilead Sciences, Inc. (GILD)

Top Social Posts

Top posts by engagements in the last XX hours

"On todays #BiotechHangout @biotech1 (Josh Schimmer) @BrianSkorney @MatteisPaul & @soowannaway (GraigSuvannavejh) will cover industry outlook for 2026 & projections for IPOs latest in Washington: FDA staffing (Richard Pazdur out Tracy Beth Heg in) vaccines (Vinay Prasads leaked memo COVID deaths + pollutant research formerFDAheadsoutline concerns inNEJM new ACIP Chairman & delayed committee vote on HBV vaccine) FDA feedback on $QUREs #HuntingtonDisease study #AlzheimersDisease agitation news ($AXSMs sNDA for AXS-05& $BMYs Cobenfy) $CAPR Ph3 DMD success & reg. next steps $PRAX SCN2A & SCN8A DEE"
X Link 2025-12-05T14:01Z 15.5K followers, 9070 engagements

"On todays #BiotechHangout @EricSchmidt151 @YaronWerber @SamFazeli8 & @t_lorriman willcover M&A news:$ALKS ups bid for $AVDL $JNJ tobuy Halda for $3B post-Ph1 data $MRKs $CDTX deal recap #biotech M&A trends Washington Policy: CDCwebsite updated on#vaccines/autism RFK Jr.speanutallergy claims &alleged tensionsw/ Makary FDA/CDC outlookplusdrug pricing: $ARWR Redemploapprovalfor #FCASat $60Ktaking on$IONS Tryngolza $NVOdrops semaglutide price $AGIO to engageFDA despite mixed Ph3 resultsrare diseaseregulatory paths & $SRPTs Elevidys label updateplusdata$NUVL $ZYME(+ new strategic focus) Roche"
X Link 2025-11-21T14:01Z 15.5K followers, 9507 engagements

"Kicking off todays show @YaronWerber talks about how $ALKS has raised its bid for $AVDL once again (after Lundbecks unexpected offer). The new offer values the company at $2.37B contingent on the Lumryz milestone tied to FDA approval of $AVDLs narcolepsy drug for idiopathic hypersomnia by the end of 2028. We're talking about a $XXX billion deal for a drug that lets say going to do $250M in sales. So it sounds expensive but remember $250M is probably going to end up being a lot higher. So if it's doing $550M to $750M thats three and half to five times which is pretty sensical. So kudos for"
X Link 2025-11-21T17:17Z 15.5K followers, XXX engagements

"Kicking off todays show @johnbstanford walks us through the major biotech provisions in the FY26 NDAA including the BIOSECURE Act and the creation of a DoD Biotech Office: This is a clear statement that biotech has now moved into the list of fields that are viewed as a national security assetThe good news is more investments through the DOD to build at home and to secure the ecosystem If youre in life sciences and you are navigating synthetic bio if youre getting involved in bio manufacturing infectious disease or the AI space theres going to be new DoD resources. #BiotechHangout"
X Link 2025-12-12T17:16Z 15.5K followers, XXX engagements

"Join @adamfeuerstein Biotech Hangout and the BioX community for a special memorial on Tuesday Dec. XX at X PM EST. Biotech Hangout will host an X Space to honor and celebrate the lives of Michelle Molly Solly (@MSollender) and Hudson Lau (@Sports_Bios). This will be an open space for the community to share memories and stories. Please save the date for this special event link coming soon"
X Link 2025-12-04T16:34Z 15.5K followers, 31.3K engagements

"Despite the FY26 NDAA offering positive elements it also comes with constraints on companies that biotech can collaborate with. There are going to be two lists that everyone has to pay attention to says @johnbstanford DOD is going to manage one. It's already existed called the 1260H list. If a company lime WuXi shows up it's going to be difficult to do business with them. There's also going to be a new list that's a little more subjective out of the White House through their Office of Management and Budget. That's probably where we will expect to see more of the companies that are CDMOs or"
X Link 2025-12-12T17:24Z 15.5K followers, XXX engagements

"Another big item coming out of the FY26 NDAA is the concept of a reverse Committee on Foreign Investment in the United States (CFIUS): There is a new outbound investment regime built into this bill. And I want to be super clear: biotech as of right now is not covered yet. In the US we have CFIUS. If a Chinese investor wants to invest in our technology there is a CFIUS review deciding whether or not that's acceptable. Recently people have been talking about reverse CFIUS. Should US capital be able to invest in countries of concern That is now going to be in place through this bill for AI"
X Link 2025-12-12T17:32Z 15.5K followers, XXX engagements

"At #ASH25 $LLYs Jaypicra announced Ph3 data highlighting fierce competition in the BTK inhibitor space with $ONC & others. The data from $LLY is very early. In general it's supposed to be safer but the safety differences honestly ended up being a little marginal says @YaronWerber. Finally $ONC has a monster pipeline in CLL including a BCL2 inhibitor in combination and a BTK degrader. Frankly they've moved their BTK degrader now to be tested head-to-head against $LLYs drug. So this is going to be fireworks for a while. Bottom line is you could argue: $ONC is no longer the absolute leader."
X Link 2025-12-12T17:50Z 15.5K followers, XXX engagements

"On today's #BiotechHangout @ColonGraceE @cngarabedian @SamFazeli8 @MatteisPaul @YaronWerber and special guest @johnbstanford will cover policy: NDAA provisions & implications for biotech industry trends & deals:big Monday w/ $1.85B inbiotech financings most in one day $XBIs sustained momentum & positive signals $LLYs acquisitive strategyplusFosun+$PFEdealfor oral GLP-1 conferences: #ASH2025 ($AZN $LLY vs $ONC$JNJ/$LEGN vs $GILD/ACLX $GMAB $TERN) #ESMOAsia25 ($BNTX Zelgen $GSK &otherADCs) $CGON at #SUO25 plus other data: $DYN positive DMD data obesity news ($GPCR $WVE Ascletis) Endpoints 100"
X Link 2025-12-12T14:36Z 15.5K followers, 6815 engagements

".@YaronWerber dives into the $GILD and $ACLX data coming out of #ASH with anito-cel emerging as a potential best-in-class BCMA CAR-T for relapsed/refractory multiple myeloma: $JNJ and $LEGN have been the leaders for BCMA in myeloma. Their efficacy has been absolutely tremendousbut they do have some noticeable toxicity and it causes low rates of Parkinsonism The drug from $GILD $ACLX does not cause any of this toxicityWhen anito-cel comes to market next year because it's safer and it doesn't have any of these issues it's really going to be probably the preferred drug. It's really going to have"
X Link 2025-12-12T18:07Z 15.5K followers, XXX engagements